160 related articles for article (PubMed ID: 32542935)
1. Loss of NF2 defines a genetic subgroup of non-FOS-rearranged osteoblastoma.
Saba KH; Cornmark L; Hofvander J; Magnusson L; Nilsson J; van den Bos H; Spierings DC; Foijer F; Staaf J; Brosjö O; Sumathi VP; Lam SW; Szuhai K; Bovée JV; Kovac M; Baumhoer D; Styring E; Nord KH
J Pathol Clin Res; 2020 Oct; 6(4):231-237. PubMed ID: 32542935
[TBL] [Abstract][Full Text] [Related]
2. Recurrent rearrangements of FOS and FOSB define osteoblastoma.
Fittall MW; Mifsud W; Pillay N; Ye H; Strobl AC; Verfaillie A; Demeulemeester J; Zhang L; Berisha F; Tarabichi M; Young MD; Miranda E; Tarpey PS; Tirabosco R; Amary F; Grigoriadis AE; Stratton MR; Van Loo P; Antonescu CR; Campbell PJ; Flanagan AM; Behjati S
Nat Commun; 2018 Jun; 9(1):2150. PubMed ID: 29858576
[TBL] [Abstract][Full Text] [Related]
3. FOS Expression in Osteoid Osteoma and Osteoblastoma: A Valuable Ancillary Diagnostic Tool.
Amary F; Markert E; Berisha F; Ye H; Gerrand C; Cool P; Tirabosco R; Lindsay D; Pillay N; O'Donnell P; Baumhoer D; Flanagan AM
Am J Surg Pathol; 2019 Dec; 43(12):1661-1667. PubMed ID: 31490237
[TBL] [Abstract][Full Text] [Related]
4. Recurrent chromosome 22 deletions in osteoblastoma affect inhibitors of the Wnt/beta-catenin signaling pathway.
Nord KH; Nilsson J; Arbajian E; Vult von Steyern F; Brosjö O; Cleton-Jansen AM; Szuhai K; Hogendoorn PC
PLoS One; 2013; 8(11):e80725. PubMed ID: 24236197
[TBL] [Abstract][Full Text] [Related]
5. FOS Rearrangement and Expression in Cementoblastoma.
Lam SW; Cleven AHG; Briaire-de Bruijn IH; Schreuder WH; Kroon HM; Savci-Heijink DC; Suurmeijer AJH; Szuhai K; Bovée JVMG; Baumhoer D
Am J Surg Pathol; 2021 May; 45(5):690-693. PubMed ID: 33653978
[TBL] [Abstract][Full Text] [Related]
6. Utility of FOS as diagnostic marker for osteoid osteoma and osteoblastoma.
Lam SW; Cleven AHG; Kroon HM; Briaire-de Bruijn IH; Szuhai K; Bovée JVMG
Virchows Arch; 2020 Mar; 476(3):455-463. PubMed ID: 31768625
[TBL] [Abstract][Full Text] [Related]
7. Clinicopathologic study of 6 cases of epithelioid osteoblastoma of the jaws with immunoexpression analysis of FOS and FOSB.
Pereira TDSF; Andrade BAB; Romañach MJ; Pereira NB; Gomes CC; Mariz BALA; Almeida OP; Agostini M; van Heerden WFP; Carlos R; Gomez RS; Fonseca FP
Oral Surg Oral Med Oral Pathol Oral Radiol; 2020 Aug; 130(2):191-199. PubMed ID: 32482537
[TBL] [Abstract][Full Text] [Related]
8. New kids on the block:
Cordier F; Creytens D
J Clin Pathol; 2023 Nov; 76(11):721-726. PubMed ID: 37553246
[No Abstract] [Full Text] [Related]
9. Epithelioid osteoblastoma with secondary aneurysmal bone cyst and FOS gene rearrangement.
Snow JT; Edgar MA; Halphen CR; Stanborough RO; Garner HW
Skeletal Radiol; 2022 Mar; 51(3):673-679. PubMed ID: 34448010
[TBL] [Abstract][Full Text] [Related]
10. Epithelioid hemangioma of bone harboring FOS and FOSB gene rearrangements: A clinicopathologic and molecular study.
Tsuda Y; Suurmeijer AJH; Sung YS; Zhang L; Healey JH; Antonescu CR
Genes Chromosomes Cancer; 2021 Jan; 60(1):17-25. PubMed ID: 33034932
[TBL] [Abstract][Full Text] [Related]
11. Methylation and copy number profiling: emerging tools to differentiate osteoblastoma from malignant mimics?
Ameline B; Nathrath M; Nord KH; de Flon FH; Bovée JVMG; Krieg AH; Höller S; Hench J; Baumhoer D
Mod Pathol; 2022 Sep; 35(9):1204-1211. PubMed ID: 35347251
[TBL] [Abstract][Full Text] [Related]
12.
Panagopoulos I; Gorunova L; Lobmaier I; Andersen K; Kostolomov I; Lund-Iversen M; Bjerkehagen B; Heim S
Cancer Genomics Proteomics; 2020; 17(2):161-168. PubMed ID: 32108038
[TBL] [Abstract][Full Text] [Related]
13. Frequent FOS Gene Rearrangements in Epithelioid Hemangioma: A Molecular Study of 58 Cases With Morphologic Reappraisal.
Huang SC; Zhang L; Sung YS; Chen CL; Krausz T; Dickson BC; Kao YC; Agaram NP; Fletcher CD; Antonescu CR
Am J Surg Pathol; 2015 Oct; 39(10):1313-21. PubMed ID: 26135557
[TBL] [Abstract][Full Text] [Related]
14. Classical osteoblastoma, atypical osteoblastoma, and osteosarcoma: a comparative study based on clinical, histological, and biological parameters.
Oliveira CR; Mendonça BB; Camargo OP; Pinto EM; Nascimento SA; Latorre Mdo R; Zerbini MC
Clinics (Sao Paulo); 2007 Apr; 62(2):167-74. PubMed ID: 17505702
[TBL] [Abstract][Full Text] [Related]
15. What's new in bone forming tumours of the skeleton?
Franceschini N; Lam SW; Cleton-Jansen AM; Bovée JVMG
Virchows Arch; 2020 Jan; 476(1):147-157. PubMed ID: 31741049
[TBL] [Abstract][Full Text] [Related]
16. Fusion of the
Panagopoulos I; Gorunova L; Lobmaier I; Lund-Iversen M; Andersen K; Holth A; Bjerkehagen B; Heim S
Cancer Genomics Proteomics; 2019; 16(5):361-368. PubMed ID: 31467230
[TBL] [Abstract][Full Text] [Related]
17. Epithelioid multinodular osteoblastoma: a clinicopathologic analysis of 26 cases.
Zon Filippi R; Swee RG; Krishnan Unni K
Am J Surg Pathol; 2007 Aug; 31(8):1265-8. PubMed ID: 17667552
[TBL] [Abstract][Full Text] [Related]
18. Usefulness of β-catenin expression in the differential diagnosis of osteosarcoma, osteoblastoma, and chondroblastoma.
Erdogan KE; Pacheco M; Gambarotti M; Magagnoli G; Sbaraglia M; Frisoni T; Righi A; Dei Tos AP
Virchows Arch; 2021 Sep; 479(3):529-535. PubMed ID: 33511430
[TBL] [Abstract][Full Text] [Related]
19. ZFP36-FOSB fusion in a haemorrhagic epithelioid and spindle cell haemangioma of bone: is there a family of FOSB-rearranged vascular neoplasms of the bone?
Keil F; Dietmaier W; Hoffstetter P; Hillmann A; Evert M
Histopathology; 2020 Feb; 76(3):490-493. PubMed ID: 31553804
[No Abstract] [Full Text] [Related]
20. Aggressive osteoblastoma: a case report involving a unique chromosomal aberration.
Baker AC; Rezeanu L; Klein MJ; Pitt MJ; Buecker P; Hersh JH; Buchino JJ; Siegal GP
Int J Surg Pathol; 2010 Jun; 18(3):219-24. PubMed ID: 18611933
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
